✦ LIBER ✦

Diborylcarbenes as Reactive Intermediates in Double 1,2-Rearrangements with Low Activation Enthalpies

✍ Scribed by Dr. Matthias Menzel; Dipl.-Chem. Heinz Jürgen Winkler; Tesfay Ablelom; Dipl.-Chem. Dirk Steiner; Dipl.-Chem. Stefan Fau; Prof. Dr. Gernot Frenking; Prof. Dr. Werner Massa; Prof. Dr. Armin Berndt

Book ID: 101555155
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 439 KB
Volume: 34
Category: Article
ISSN: 0044-8249
DOI: 10.1002/anie.199513401

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of 2,3-dimethylene-1, 4-cyclohe

The role of 2,3-dimethylene-1, 4-cyclohexadiyl diradical as a reactive intermediate in some rearrangement reactions

✍ Karl Jug; Rüdiger Iffert 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 454 KB

Modeling catalytic reactions with transi

Modeling catalytic reactions with transition metal atoms. 1. Synthesis and characterization of reactive intermediates in the nickel-ethylene system, (C2H4)nNi (where n = 1, 2, or 3) in low temperature matrices

✍ Huber, H.; Ozin, G. A.; Power, W. J. 📂 Article 📅 1976 🏛 American Chemical Society 🌐 English ⚖ 469 KB

A phase 2, randomized, double-blind, mul

A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediate-1-risk myelodysplastic syndrome

✍ Garcia-Manero, Guillermo; Gartenberg, Gary; Steensma, David P.; Schipperus, Mart 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 1013 KB

2-(Lithiomethyl)-1-methylimidazole as a

2-(Lithiomethyl)-1-methylimidazole as a non-reactive bulk base and its novel mixed dimer with a chiral lithium amide in catalytic stereoselective deprotonationElectronic supplementary information (ESI) available: 13C NMR spectra and PM3 enthalpies. See http://www.rsc.org/suppdata/p1/b1/b104336f/

✍ Nilsson Lill, Sten O.; Pettersen, Daniel; Amedjkouh, Mohamed; Ahlberg, Per 📂 Article 📅 2001 🏛 Royal Society of Chemistry ⚖ 395 KB

A Double-blind, randomized, placebo-cont

A Double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2336805 when given as monotherapy and in combination with peginterferon alfa-2a and ribavirin in hepatitis C virus genotype 1-infected

✍ Gardner, Stephen; Cutrell, Amy; Elko-Simms, Cindy; Adkison, Kimberly; Hamatake, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB